𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase

✍ Scribed by Jing Li; Neil Sidell


Publisher
John Wiley and Sons
Year
2005
Tongue
French
Weight
355 KB
Volume
117
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Syk, a nonreceptor type of protein tyrosine kinase widely expressed in hematopoietic cells, is a candidate suppressor gene in human breast cancer. Reduced expression of Syk protein is correlated with poor prognosis, while its overexpression can reduce the malignant phenotype of breast cancer cells. The mechanism of action of Syk remains unclear. In this study, we utilized low Syk-expressing, highly invasive MDA-MB-231 and high Syk-expressing, less invasive MCF-7 breast cancer cells to investigate the possibility that part of the functional effects of Syk are mediated by cytokines known to play roles in cell migration, invasion or metastasis. Using protein array technology, we determined that MDA-MB-231 cells secrete a number of cytokines known to regulate cellular growth and motility. One such cytokine, growth-related oncogene (GRO), has previously not been described in breast cancer. Of the compounds detected in the culture supernatant of MDA-MB-231, GRO was the only one that was significantly altered by modulation of Syk expression; overexpression of Syk caused a marked reduction in secreted levels of GRO. Conversely, downregulation of the relatively high levels of Syk produced in MCF-7 cells upregulated GRO secretion. At the mRNA level, overexpression of Syk in MDA-MB-231 differentially regulated the 3 GRO isotypes such that message levels of GROalpha and gamma were downregulated while that of GRObeta was not affected. Matrigel invasion assays demonstrated a link between Syk expression and resulting GRO activity in mediating the invasive potential of MDA-MB-231 cells. In summary, our findings provide evidence that human breast cancer cells express and secrete GRO and implicate this cytokine as an essential mediator of the antiinvasive properties of Syk tyrosine kinase.


📜 SIMILAR VOLUMES


Angiotensin II activates extracellular s
✍ S. Greco; A. Muscella; M.G. Elia; P. Salvatore; C. Storelli; A. Mazzotta; C. Man 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB 👁 2 views

## Abstract Angiotensin II (Ang II) induces, through AT1, intracellular Ca^2+^ increase in both normal and cancerous breast cells in primary culture (Greco et al., 2002 Cell Calcium 2:1–10). We here show that Ang II stimulated, in a dose‐dependent manner, the 24 h‐proliferation of breast cancer cel

Cell growth inhibition by all-trans reti
✍ Shino Nakagawa; Teruhiko Fujii; Goro Yokoyama; Marcelo G. Kazanietz; Hideaki Yam 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB

## Abstract All‐trans retinoic acid (ATRA), a synthetic derivative of vitamin A, inhibits the growth of breast cancer cells. To elucidate the mechanism by which ATRA causes cell growth inhibition, we examined changes in cell cycle and intracellular signaling pathways, focusing on protein kinase C (

Activation of MAP kinase by muscarinic c
✍ Eugenio Jiménez; Mercedes Montiel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 1 views

## Abstract Carbachol (Cch), a muscarinic acetylcholine receptor (mAChR) agonist, increases intracellular‐free Ca^2+^ mobilization and induces mitogen‐activated protein kinase/extracellular signal‐regulated kinase (MAPK/ERK) phosphorylation in MCF‐7 human breast cancer cells. Pretreatment of cells

Effects of tyrosine kinase inhibitors on
✍ Jeffrey W. Clark; Anabela Santos-Moore; Lisa E. Stevenson; A. Raymond Frackelton 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 698 KB

Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr